Gastrointestinal chronopharmacology: Physiology, pharmacology and therapeutic implications

https://doi.org/10.1016/0163-7258(92)90049-6Get rights and content

Abstract

This chapter discusses the influence of ultradian and circadian rhythms of gastrointestinal motor and secretory function on the action of orally administered drugs. Most drugs exhibit more rapid absorption in the morning compared to the evening due, in part, the circadian alterations in gastric emptying. Gastric acid secretion and gastrointestinal toxicity to oral drugs also display circadian rhythmicity. These observations provide a rationale for use or avoidance of drugs based on time-of-day dosing considerations. The chronopharmacological behavior of a drug may thus play an important role in the effectiveness of any oral medication treatment schedule.

References (69)

  • N. Aymard et al.

    Chronobiological changes in the pharmacokinetics of dipotassium clorazepate, a benzodiazepine

  • M.A. Ballesteros et al.

    Bolus or intravenous infusion of ranitidine: Effects on gastric pH and acid secretion

    Ann. intern. Med.

    (1990)
  • P.M. Belanger

    Chronobiological variations in the hepatic elimination of drugs and toxic chemical agents

    A. Rev. Chronopharmac.

    (1988)
  • C. Bogentoft et al.

    Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms

    Eur. J. clin. Pharmac.

    (1978)
  • G. Bretzke

    Monat und Jahreszeitliche Verteilung des Ulcus Ventriculi und Duodeni in Endoskopischer Untersuchungsgruppe

    Z. ges. in Med.

    (1985)
  • C.M. Brophy et al.

    Variability of gastric emptying measurements in man employing standardized radiolabeled meals

    Dig. Dis. Sci.

    (1986)
  • J. Clench et al.

    Circadian changes in the bioavailability and effects of indomethacin in healthy subjects

    Eur. J. clin. Pharmac.

    (1981)
  • A. DiSanto et al.

    Chronobioavailability of three erythromycin test preparations assessed by each of four indices: time to peak, nadir and area

    Chronobiologia

    (1975)
  • H. Echizen et al.

    Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects

    Clin. Pharmac. Ther.

    (1988)
  • P. Fleckenstein et al.

    Electrical spike activity in the human small intestine

    Am. J. Dig. Dis.

    (1978)
  • K. Frislid et al.

    Prolonged influence of meal on the effect of ranitidine

    Scand. J. Gastroenterol.

    (1985)
  • K. Gibinski

    A role of seasonal periodicity in peptic ulcer disease

    Chronobiol. Int.

    (1987)
  • K. Gibinski et al.

    Seasonal occurence of abdominal pain and endoscopic findings in patients with gastric and duodenal ulcer disease

    Scand. J. Gastroenterol.

    (1982)
  • J. Heepe et al.

    Zur Häufigkeit und Lokalisation Gastroduodenalen Erosionen und Ulzere

    Med. Welt.

    (1985)
  • C.W. Howden et al.

    Single nocturnal doses of pirenzapine effectively inhibit overnight gastric secretion

    Hepatogastroenterology

    (1986)
  • W.J.M. Hrushesky

    Chemotherapy timing: An important variable in toxicity and response

  • E.C. Huskisson

    Chronopharmacology of anti-rheumatic drugs with special reference to indomethacin

  • D.A. Johnston et al.

    The effect of food on ranitidine-induced inhibition of nocturnal gastric secretion

    Aliment. Pharmac. Ther.

    (1988)
  • A.I. Karvonen

    Occurrence of gastric mucosal erosions in association with other upper gastrointestinal diseases, especially peptic ulcer disease, as revealed by elective gastroscopy

    Scand. J. Gastroenterol.

    (1982)
  • G.M. Kyle et al.

    Circadian rhythm in the pharmacokinetics of orally administered theophylline

  • G.M. Kyle et al.

    Indirect monitoring of theophylline blood levels utilizing saliva: A practical non-invasive approach to verifying dosage and understanding temporal variability in pharmacokinetics

  • G. Labrecque et al.

    24-Hour variations in the distribution of labeled microspheres to the intestine, liver and kidneys

    A. Rev. Chronopharmac.

    (1988)
  • B. Langner et al.

    Carcadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects

    Eur. J. clin. Pharmac.

    (1988)
  • Cited by (0)

    View full text